University Hospitals Birmingham NHS Foundation Trust
Chapters
Medicines A–Z
Reports
News
Links
Procedures
Loading results...
View full results list
Medicines Formulary
Reports
Entries that have NICE TAs
Status
Drug name
NICE TAs
Comments
Sunitinib capsules
TA178 - Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma
(Negative TA)
TA169 - Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma
TA179 - Sunitinib for the treatment of gastrointestinal stromal tumours
TA449 - Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease
Hospital use only
Tacrolimus 0.03% ointment (30g)
TA82 - Tacrolimus and pimecrolimus for atopic eczema
Tacrolimus 0.1% ointment (30g)
TA82 - Tacrolimus and pimecrolimus for atopic eczema
Tacrolimus capsules (Prograf)
TA85 - Immunosuppressive therapy for renal transplantation in adults
New post-transplant
Tacrolimus capsules (Prograf)#amber
TA85 - Immunosuppressive therapy for renal transplantation in adults
Post-transplant pre 2015
Tacrolimus prolonged release capsules (Advagraf)
TA85 - Immunosuppressive therapy for renal transplantation in adults
New post-transplant
Tacrolimus prolonged release capsules (Advagraf)#amber
TA85 - Immunosuppressive therapy for renal transplantation in adults
Post-transplant pre 2015
Tebentafusp (Kimmtrak®)
NICE TA 1027 Tebentafusp for treating advanced uveal melanoma
Teclistamab (Tecvayli®)
NICE TA 1015 Teclistamab for treating relapsed and refractory multiple myeloma after 3 or more treatments
Teduglutide (Revestive®)
TA804: Teduglutide for treating short bowel syndrome
First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
Next page
Last page
Back to top
